Candel Therapeutics, Inc. (CADL)

NASDAQ: CADL · IEX Real-Time Price · USD

6.25

-0.05 (-0.79%)

At close: Jul 2, 2024, 4:00 PM

6.16

-0.09 (-1.44%)

After-hours: Jul 2, 2024, 7:57 PM EDT

Candel Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	186	43	52	224	-	-
Market Cap Growth	18.77%	-17.80%	-76.95%	-	-	-
Enterprise Value	181	30	4	142	-34	-45
PE Ratio	-	-1.12	-2.75	-6.21	-	-
PB Ratio	31.10	3.34	1.08	3.50	-	-
P/FCF Ratio	-1.44	-1.23	-1.58	-9.33	-	-
P/OCF Ratio	-1.46	-1.24	-1.65	-10.10	-	-
EV/EBITDA Ratio	-1.24	-0.87	-0.26	-3.96	1.93	4.82
EV/EBIT Ratio	-1.19	-0.84	-0.25	-3.93	1.92	4.79
EV/FCF Ratio	-1.29	-0.86	-0.13	-5.90	3.23	8.37
Debt / Equity Ratio	3.53	1.79	0.48	0.01	-0.04	-0.05
Debt / EBITDA Ratio	-0.63	-0.67	-1.42	-0.02	-0.05	-0.05
Debt / FCF Ratio	-0.66	-0.66	-0.70	-0.02	-0.09	-0.08
Quick Ratio	1.92	2.52	12.52	15.49	7.44	31.96
Current Ratio	2.01	2.59	12.81	15.84	7.46	32.06
Interest Coverage	-13.20	-13.62	-10.00	-680.58	-	-
Return on Equity (ROE)	-206.10%	-142.90%	-33.60%	-256.00%	111.90%	-
Return on Assets (ROA)	-82.50%	-69.90%	-21.00%	-57.60%	-42.00%	-
Return on Capital (ROIC)	-135.46%	-108.12%	-49.42%	-39.96%	61.62%	120.27%
Earnings Yield	-20.09%	-89.24%	-36.34%	-16.10%	-	-
FCF Yield	-17.30%	-81.21%	-63.26%	-10.72%	-	-
Buyback Yield / Dilution	-0.96%	-0.39%	-52.72%	-62.49%	-0.71%	-
Total Shareholder Return	-0.96%	-0.39%	-52.72%	-62.49%	-0.71%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).